FDA Inspection 1216057 — Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. on July 28, 2023 in Jinhua. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinhua (China)